Petros Pharmaceuticals, Inc. (PTPI) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

$1.9M

Total Assets (FY2025)

$5.2M

Total Equity (FY2025)

$2.9M

Cash Flows from Operating Activities (FY2025)

-$6.7M

Source: Petros Pharmaceuticals, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.